CMS finalizes a 1.91% cut to the Medicare anesthesia conversion factor for 2027

CMS has finalized a 1.91% cut to the Medicare anesthesia conversion factor for 2027, deeper than the 1.38% reduction it proposed in July, according to Becker's ASC Review. Under the 2027 physician fee schedule final rule released Nov. 4, the rate falls to $20.1056 from $20.4976 in 2026. For providers qualifying through advanced alternative payment models, it falls 1.42%, to $20.3068 from $20.5998. The broader physician conversion factor falls 2.31% for most physicians, to $32.63, the same report notes.

The driver is mainly the expiration of a one-year 2.5% increase Congress authorized for 2026, partly offset by statutory updates of 0.25% for most physicians and 0.75% for qualifying APM participants, plus an estimated -0.12% work RVU adjustment, per a CMS fact sheet cited by Becker's. Base units are unchanged. Per case, the effect looks small: a 180-minute lumbar fusion drops $9.80, a 120-minute total knee $5.88, a 30-minute colonoscopy $2.35 and a 15-minute cataract case $1.96, using the publication's example times. Under medical direction, each provider's 50% share falls by half those amounts.

The consequence is in volume and in contracts. In a third-quarter Ambulatory Surgery Center Association survey, 31% of ASCs said they already offer financial assistance in anesthesia contracts, about the same as in 2024, Becker's reports. A lower Medicare rate puts pressure on those stipends and on anesthesia group negotiations. The American Society of Anesthesiologists said in September comments that the update "falls far short of keeping pace with rising practice costs, workforce expenses, and inflation."

The rule also narrows a proposed same-day E/M cut: it now applies only alongside 0-day global procedures, with the lower-valued service paid at 80% rather than the proposed 50%. Traditional MIPS ends after the 2030 performance year, with MIPS Value Pathways taking over in 2031.

What the evidence shows is the rate and its arithmetic. It does not show what any automation tool returns. The move for CFOs and operations leaders: rerun the 2027 anesthesia revenue forecast at $20.1056, multiplied across your actual case mix and anesthesia times, and bring that number to anesthesia contract discussions early. For Chief AI Officers, the task is to identify where documentation and coding automation can capture time units accurately and reduce rework, and to measure that return locally before counting on it to close the gap. Accurate capture protects revenue without asking clinicians to absorb more administrative work.

You are a revenue cycle and finance advisor to the executive team of [your organization], a medical organization that bills Medicare for anesthesia services.

Context: Under the 2027 physician fee schedule final rule released Nov. 4, CMS finalized a 1.91% cut to the Medicare anesthesia conversion factor. That is deeper than the 1.38% cut CMS proposed in July. The final rate is $20.1056, down from $20.4976 in 2026. Becker's ASC Review reported these figures from the CMS final rule. The reporting shows the rate and its arithmetic. It does not show what any automation tool returns.

Task: Rerun our 2027 Medicare anesthesia revenue forecast at $20.1056 instead of $20.4976, using our own case mix and anesthesia times. Calculate the gap against our current forecast. Then identify where documentation and coding automation could capture time units accurately and reduce rework, and describe how we would measure that return locally before counting on it to close the gap.

Use these inputs:
[your current 2027 anesthesia revenue forecast]
[your 2027 Medicare anesthesia case volume by procedure type]
[your average base units and anesthesia minutes per procedure type]
[your current documentation and coding tools or vendors]
[your anesthesia contract renewal or negotiation dates]

Output: A one-page memo for the executive team with these sections: Rate change, Revised forecast and gap, Contract timing, Automation candidates, How we will measure return, Open questions to verify.

Guardrails: Use only the facts given here and the inputs I have filled in. Cite Becker's ASC Review by name for the rate figures. Do not invent savings, vendor results or outcomes for any automation tool. Flag anything uncertain or that should be verified against the CMS final rule itself. Do not request or include any patient data. Nothing here is medical advice. Label the memo as a draft for the team to check before it is used.